Ascendis Pharma
ASND
$124.04
Share price
-0.62%
Change (1 day)
28.42%
Change (1 year)
Categories
Ascendis Pharma (ASND) - Total debt
Total debt on the balance sheet as of March 2024 : $0.72 B
According to Ascendis Pharma 's latest financial reports the company's total debt is $0.72 B. A company’s total debt is the sum of all current and non-current debts.
Ascendis Pharma - Total debt on balance sheet (from 2013 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.71 B | 30.83% |
| 2022-12-31 | $0.54 B | 358.03% |
| 2021-12-31 | $0.11 B | 5.07% |
| 2020-12-31 | $0.11 B | 175.78% |
| 2019-12-31 | $41.02 M | |
| 2018-12-31 | $N/A | |
| 2014-12-31 | $N/A | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $0.28 M | -45.91% |
| 2011-12-31 | $0.51 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Akebia Therapeutics AKBA | $48.12 M | -93.34% | 🇺🇸 USA |
 Affimed
AFMD | $21.39 M | -97.04% | 🇩🇪 Germany |
 Advaxis ADXS | $8.31 M | -98.85% | 🇺🇸 USA |